{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T23:48:39Z","timestamp":1784764119812,"version":"3.55.0"},"reference-count":57,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"47","license":[{"start":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T00:00:00Z","timestamp":1700784000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,11,24]]},"abstract":"<jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Kimura's disease (KD) is a rare and chronic eosinophilic related-disease, characterized by subcutaneous tissue masses, regional enlarged lymph nodes, hypereosinophilia and elevated serum IgE. KD usually affects young adults in the Asian population. In Western countries, the clinical and biological presentation of KD is often unknown, delaying the diagnosis. Therapeutic management is not standardized and despite recent advances, remission from KD can be difficult to achieve, especially in relapse situations.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>We report the case of an non-Asian man with KD, initially misdiagnosed as lymphoma. We focus on his long-lasting clinical course with 20 years of recurrence despite several therapeutic lines.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnoses and interventions:<\/jats:title>\n            <jats:p>We have emphasized the key points of the KD diagnostic challenge. We chose to focus on hemopathies as diagnostic traps to illustrate several overlapping features that blur frontiers with KD. With regard to treatments, lessons can be learned from the use of the therapeutic backbone, which relies on excision surgery, radiotherapy and corticosteroids.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>Advancements in KD pathogenesis have highlighted the pivotal role of Th2 lymphocytes driving eosinophil activation. Directly inspired by eosinophilic and allergic field practices, targeted therapies, such as dupilumab, provide hope for potential curative options.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>Finally, we propose a therapeutic plan to treat newly diagnosed KD and discuss options for relapsing entities.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000034191","type":"journal-article","created":{"date-parts":[[2023,12,4]],"date-time":"2023-12-04T19:05:11Z","timestamp":1701716711000},"page":"e34191","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":11,"title":["Diagnostic challenges and updated therapeutic strategies of Kimura\u2019s disease: A case report successfully treated by dupilumab and review"],"prefix":"10.1097","volume":"102","author":[{"given":"Stephanie","family":"Cordeil","sequence":"first","affiliation":[{"name":"Department of Hematology, Lyon Sud Hospital, Hospices Civils de Lyon, Pierre-B\u00e9nite, France"},{"name":"Claude Bernard Lyon 1 University, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Hermine","sequence":"additional","affiliation":[{"name":"Department of Hematology and Imagine Institute, INSERM UMR 1163 and CNRS ERL 8254, Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutic Implication, Necker Hospital, Paris, France"},{"name":"University of Paris Descartes, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Hot","sequence":"additional","affiliation":[{"name":"Claude Bernard Lyon 1 University, Lyon, France"},{"name":"Department of Internal Medicine, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250524","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.blre.2009.01.001","article-title":"Pathogenesis, classification, and therapy of eosinophilia and eosinophil disorders.","volume":"23","author":"Valent","year":"2009","journal-title":"Blood Rev"},{"key":"R2-20250524","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2332\/allergolint.O-06-442","article-title":"Serum concentrations of eosinophil cationic protein and eosinophils of patients with Kimura\u2019s disease.","volume":"56","author":"Ohta","year":"2007","journal-title":"Allergol Int"},{"key":"R3-20250524","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/ajh.21121","article-title":"Eosinophilia with stroke in a Chinese patient: Kimura\u2019s disease complicated with fibroblastic endocarditis, first report.","volume":"83","author":"Barge","year":"2008","journal-title":"Am J Hematol"},{"key":"R4-20250524","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1253\/jcj.63.141","article-title":"A case of eosinophilic myocarditis complicated by Kimura\u2019s disease (Eosinophilic Hyperplastic Lymphogranuloma) and Erythroderma.","volume":"63","author":"Nakagawa","year":"1999","journal-title":"Jpn Circ J"},{"key":"R5-20250524","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.4103\/jfmpc.jfmpc_373_19","article-title":"Mepolizumab as an effective treatment for Kimura\u2019s disease associated with ulcerative colitis: a case report.","volume":"8","author":"Al Shammari","year":"2019","journal-title":"J Family Med Prim Care"},{"key":"R6-20250524","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/BF02779234","article-title":"Kimura\u2019s disease (angiolymphoid hyperplasia with eosinophilia) associated with ulcerative colitis.","volume":"28","author":"Shimamoto","year":"1993","journal-title":"Gastroenterol Jpn"},{"key":"R7-20250524","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0272-6386(88)80143-4","article-title":"Nephrotic syndrome associated with Kimura\u2019s disease.","volume":"11","author":"Whelan","year":"1988","journal-title":"Am J Kidney Dis"},{"key":"R8-20250524","doi-asserted-by":"crossref","first-page":"332","DOI":"10.5414\/CN108749","article-title":"Clinicopathological features and prognosis of Kimura\u2019s disease with renal involvement in Chinese patients.","volume":"85","author":"Chen","year":"2016","journal-title":"Clin Nephrol"},{"key":"R9-20250524","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/00000478-198903000-00001","article-title":"Lymphadenopathy of Kimura\u2019s disease.","volume":"13","author":"Hui","year":"1989","journal-title":"Am J Surg Pathol"},{"key":"R10-20250524","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/00000478-200404000-00010","article-title":"Kimura disease: a clinicopathologic study of 21 cases.","volume":"28","author":"Chen","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"R11-20250524","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.humimm.2013.06.001","article-title":"Increased CD45RO+ CD62L+ CD4+ T-cell subpopulation responsible for Th2 response in Kimura\u2019s disease.","volume":"74","author":"Yamazaki","year":"2013","journal-title":"Hum Immunol"},{"key":"R12-20250524","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.anl.2010.03.011","article-title":"Increase of Th2 and Tc1 cells in patients with Kimura\u2019s disease.","volume":"38","author":"Ohta","year":"2011","journal-title":"Auris Nasus Larynx"},{"key":"R13-20250524","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1046\/j.1365-2222.2002.01552.x","article-title":"Mast cells and T cells in Kimura\u2019s disease express increased levels of interleukin-4, interleukin-5, eotaxin and RANTES.","volume":"32","author":"Kimura","year":"2002","journal-title":"Clin Exp Allergy"},{"key":"R14-20250524","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1586\/ehm.11.81","article-title":"Pathogenesis and classification of eosinophil disorders: a review of recent developments in the field.","volume":"5","author":"Valent","year":"2012","journal-title":"Expert Rev Hematol"},{"key":"R15-20250524","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.cyto.2015.05.023","article-title":"Commentary: IL-4 and IL-13 receptors and signaling.","volume":"75","author":"McCormick","year":"2015","journal-title":"Cytokine"},{"key":"R16-20250524","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/00015550510027414","article-title":"Kimura\u2019s disease with prolonged history and prominent vascular involvement.","volume":"1","author":"Komine","year":"2005","journal-title":"Acta Derm Venereol"},{"key":"R17-20250524","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1006\/clin.1994.1142","article-title":"Kimura\u2019s disease with high serum levels of eosinophil cationic protein and major basic protein.","volume":"72","author":"Morita","year":"1994","journal-title":"Clin Immunol Immunopathol"},{"key":"R18-20250524","doi-asserted-by":"crossref","first-page":"295","DOI":"10.5414\/CNP61295","article-title":"Membranous nephropathy accompanied by HHV8-DNA-positive angiolymphoid hyperplasia of the skin with eosinophilia: lack of HHV8 viral DNA in the kidney biopsy.","volume":"61","author":"Kem\u00e9ny","year":"2004","journal-title":"Clin Nephrol"},{"key":"R19-20250524","doi-asserted-by":"crossref","first-page":"ciw135","DOI":"10.1093\/cid\/ciw135","article-title":"Human polyomavirus-6 infecting lymph nodes of a patient with an angiolymphoid hyperplasia with eosinophilia or Kimura disease.","volume":"62","author":"Rascovan","year":"2016","journal-title":"Clin Infect Dis"},{"key":"R20-20250524","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.ejrad.2010.09.016","article-title":"Kimura\u2019s disease: the CT and MRI characteristics in fifteen cases.","volume":"80","author":"Zhang","year":"2011","journal-title":"Eur J Radiol"},{"key":"R21-20250524","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.otohns.2007.03.027","article-title":"Kimura disease: diagnosis and prognostic factors.","volume":"137","author":"Iwai","year":"2007","journal-title":"Otolaryngol Head Neck Surg"},{"key":"R22-20250524","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1093\/ajcp\/102.3.316","article-title":"Cytologic features of Kimura\u2019s disease in fine-needle aspirates. A study of eight cases.","volume":"102","author":"Chow","year":"1994","journal-title":"Am J Clin Pathol"},{"key":"R23-20250524","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1159\/000439346","article-title":"Retrospective multicentric study of 25 kimura disease patients: emphasis on therapeutics and shared features with cutaneous IgG4-related disease.","volume":"231","author":"Kottler","year":"2015","journal-title":"Dermatology"},{"key":"R24-20250524","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s13139-014-0285-1","article-title":"Kimura disease simulating Hodgkin\u2019s lymphoma on 18F FDG PET-CT: report of a case.","volume":"48","author":"Yang","year":"2014","journal-title":"Nucl Med Mol Imag"},{"key":"R25-20250524","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1097\/00000478-200208000-00016","article-title":"Analysis of Clonality in Kimura\u2019s disease.","volume":"26","author":"Chim","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"R26-20250524","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1034\/j.1600-0560.2001.280705.x","article-title":"Polymerase chain reaction (PCR) for human herpesvirus 8 and heteroduplex PCR for clonality assessment in angiolymphoid hyperplasia with eosinophilia and Kimura\u2019s disease.","volume":"28","author":"Jang","year":"2001","journal-title":"J Cutan Pathol"},{"key":"R27-20250524","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1136\/bjo.83.7.878c","article-title":"Kimura\u2019s disease: no evidence of clonality.","volume":"83","author":"Chim","year":"1999","journal-title":"Br J Ophthalmol"},{"key":"R28-20250524","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1097\/00000478-200305000-00018","article-title":"Further analysis of clonality in Kimura\u02bcs disease.","volume":"27","author":"Chim","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"R29-20250524","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1093\/qjmed\/hcz312","article-title":"Kimura\u2019s disease: effects of age on clinical presentation.","volume":"113","author":"Kakehi","year":"2020","journal-title":"QJM"},{"key":"R30-20250524","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.amjoto.2011.05.005","article-title":"Kimura disease: diagnostic challenges and clinical management.","volume":"33","author":"Kapoor","year":"2012","journal-title":"Am J Otolaryngol"},{"key":"R31-20250524","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12893-019-0673-7","article-title":"Clinical analysis of Kimura\u2019s disease in 24 cases from China.","volume":"20","author":"Zhang","year":"2020","journal-title":"BMC Surg"},{"key":"R32-20250524","doi-asserted-by":"crossref","first-page":"511","DOI":"10.3109\/02841868909092260","article-title":"Radiation therapy in Kimura\u2019s disease.","volume":"28","author":"Itami","year":"1989","journal-title":"Acta Oncol"},{"key":"R33-20250524","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0360-3016(97)00813-4","article-title":"Radiotherapy for Kimura\u2019s disease: the optimum dosage.","volume":"40","author":"Hareyama","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R34-20250524","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0360-3016(97)89487-4","article-title":"Radiation treatment in patients with recurrent Kimura\u2019s disease.","volume":"38","author":"Kim","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R35-20250524","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1186\/s12882-018-1123-y","article-title":"Nephrotic syndrome associated with Kimura\u2019s disease: a case report and literature review.","volume":"19","author":"Ren","year":"2018","journal-title":"BMC Nephrol"},{"key":"R36-20250524","first-page":"119","article-title":"Long-term effects of steroid treatment on nephrotic syndrome associated with Kimura\u2019s disease and a review of the literature.","volume":"37","author":"Matsuda","year":"1992","journal-title":"Clin Nephrol"},{"key":"R37-20250524","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.nephro.2013.09.001","article-title":"La maladie de Kimura: une cause m\u00e9connue de syndrome n\u00e9phrotique \u00e0 l\u00e9sions glom\u00e9rulaires minimes de l\u2019adulte.","volume":"10","author":"Shehwaro","year":"2014","journal-title":"N\u00e9phrol Th\u00e9rap"},{"key":"R38-20250524","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/s004670050798","article-title":"Steroid-sensitive nephrotic syndrome associated with Kimura disease.","volume":"14","author":"Nakahara","year":"2000","journal-title":"Pediatr Nephrol"},{"key":"R39-20250524","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/art.20908","article-title":"Cetirizine: an effective agent in Kimura\u2019s disease.","volume":"53","author":"Ben-Chetrit","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R40-20250524","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1177\/2040620718780370","article-title":"A case series of Kimura\u2019s disease: a diagnostic challenge.","volume":"9","author":"Kumar","year":"2018","journal-title":"Ther Adv Hematol"},{"key":"R41-20250524","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.jdcr.2017.04.010","article-title":"Treatment of Kimura disease with mycophenolate mofetil monotherapy.","volume":"3","author":"Shah","year":"2017","journal-title":"JAAD Case Rep"},{"issue":"5 Pt 2","key":"R42-20250524","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0190-9622(99)70354-3","article-title":"Successful treatment of Kimura\u2019s disease with cyclosporine.","volume":"41","author":"Kaneko","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"R43-20250524","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1080\/09546630510044003","article-title":"Treatment of Kimura\u2019s disease with cyclosporine.","volume":"16","author":"Wang","year":"2005","journal-title":"J Dermatolog Treat"},{"key":"R44-20250524","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1016\/j.jaip.2021.02.049","article-title":"Mepolizumab-responsive Kimura disease.","volume":"9","author":"Kinoshita","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R45-20250524","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1001\/jamadermatol.2021.5885","article-title":"Treatment of Kimura disease with dupilumab.","volume":"158","author":"Teraki","year":"2022","journal-title":"JAMA Dermatol"},{"key":"R46-20250524","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.anl.2013.12.006","article-title":"Anti-IgE therapy to Kimura\u2019s disease: a pilot study.","volume":"41","author":"Nonaka","year":"2014","journal-title":"Auris Nasus Larynx"},{"key":"R47-20250524","first-page":"18","article-title":"Effects of cyclosporine, azathioprine and prednisone on Kimura\u2019s disease and focal segmental glomerulosclerosis in renal transplant patients.","volume":"45","author":"Senel","year":"1996","journal-title":"Clin Nephrol"},{"key":"R48-20250524","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.abd.2019.03.006","article-title":"Treatment of Kimura\u2019s disease with oral corticosteroid and methotrexate.","volume":"95","author":"Ma","year":"2020","journal-title":"An Bras Dermatol"},{"key":"R49-20250524","doi-asserted-by":"crossref","first-page":"c55","DOI":"10.1159\/000178980","article-title":"Kimura disease: a case report and review of the Chinese literature.","volume":"111","author":"Wang","year":"2009","journal-title":"Nephron Clin Pract"},{"key":"R50-20250524","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1111\/j.1365-2133.1997.tb01562.x","article-title":"In vivo expression of IL-4, IL-5, IL-13 and IFN-gamma mRNAs in peripheral blood mononuclear cells and effect of cyclosporin A in a patient with Kimura\u2019s disease.","volume":"137","author":"Katagiri","year":"1997","journal-title":"Br J Dermatol"},{"key":"R51-20250524","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s10067-011-1689-2","article-title":"Effective treatment of Kimura\u2019s disease with leflunomide in combination with glucocorticoids.","volume":"30","author":"Dai","year":"2011","journal-title":"Clin Rheumatol"},{"key":"R53-20250524","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1097\/DAD.0b013e3181acedf8","article-title":"Concomitant occurrence of Kimura disease and mycosis Fungoides in a Lebanese woman: significance and response to rituximab.","volume":"31","author":"Ghosn","year":"2009","journal-title":"Am J Dermatopathol"},{"key":"R54-20250524","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1056\/NEJMoa070812","article-title":"Treatment of patients with the hypereosinophilic syndrome with mepolizumab.","volume":"358","author":"Rothenberg","year":"2008","journal-title":"N Engl J Med"},{"key":"R55-20250524","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1007\/s00277-022-04873-0","article-title":"Successful treatment of Kimura disease with benralizumab.","volume":"101","author":"Szeto","year":"2022","journal-title":"Ann Hematol"},{"key":"R56-20250524","doi-asserted-by":"crossref","first-page":"S110","DOI":"10.1097\/SAP.0000000000003106","article-title":"Kimura disease of the thigh treated with surgical excision and dupilumab.","volume":"88","author":"Huang","year":"2022","journal-title":"Ann Plast Surg"},{"key":"R57-20250524","doi-asserted-by":"crossref","first-page":"e15674","DOI":"10.1111\/dth.15674","article-title":"Dupilumab for recalcitrant Kimura disease.","volume":"35","author":"Bellinato","year":"2022","journal-title":"Dermatol Ther"},{"key":"R58-20250524","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.autrev.2010.11.009","article-title":"The kaleidoscope of glucorticoid effects on immune system.","volume":"10","author":"Zen","year":"2011","journal-title":"Autoimmun Rev"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000034191","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T18:01:09Z","timestamp":1748109669000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000034191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,24]]},"references-count":57,"journal-issue":{"issue":"47","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000034191","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,24]]}}}